InvestIdeas

Bill Ackman of Pershing Square Capital Management, is betting that HK, will repeg the HKD to a newer range, within 12 to 18 months.

If his trade proves correct ( HKD and Options on the HKD ), it will return 100 times his bet.

Source: CNBC

[b]Bill Ackman Is Preparing For The Next Crash[/b] By Chris Mydlo

In Pershing Square’s quarterly newsletter released yesterday, August 13, Bill Ackman stated that he is planning an initial public offering of Pershing Square Holdings, Ltd targeted for later this year. The plan is for the closed-end fund to be listed on the London Stock Exchange under the symbol “PSH.”

The reason for the IPO is to help alleviate the risk of investor redemptions. In the letter, Ackman said the following about redemptions:


Source: GuruFocus

http://www.thetradingreport.com/2014/08 ... ext-crash/

‘Smart Money’ Stocks: Bill Ackman (Pershing Square Capital Management, LP)

Bill Ackman made quite a splash at this year’s Ira Sohn Conference when he compared Valeant Pharmaceuticals Intl Inc (NYSE:VRX) to a young version of Warren Buffett’s Berkshire Hathaway, calling both “platforms” for investments in other businesses.

Right or wrong, Ackman certainly is one to eat his own cooking. Ackman’s Pershing Square Capital Management initiated a massive position in Valeant in the first quarter. This pharma “platform” now makes up fully 26% of his long portfolio. He’s also enjoyed a fantastic profit in a very short period of time. He bought at an average price of $177 per share, and as of this writing shares traded hands at $227.

Is there any upside left?

Maybe. In Ackman’s Ira Sohn presentation, he suggested the company was worth $250 per share or more. While Ackman is a brilliant investor, I might wait for a pullback before following him into this trade.

Valeant failed last year in its attempt to buy Botox maker Allergan Inc (NYSE:AGN), which was, until this quarter, Ackman’s largest holding. Allergan was instead acquired by Actavis PLC (NYSE:ACT), which coincidentally is a new holding of Ackman’s. Pershing Square initiated a new position in Actavis last quarter, and the stock now makes up about 2.7% of the portfolio.

If there is a theme to Ackman’s investing this year, it is healthcare. More than 40% of his fund is currently dedicated to health and pharmaceutical stocks.

Source: Investor Place

‘Smart Money’ Stocks: Bill Ackman (Pershing Square Capital Management, LP)

Bill Ackman made quite a splash at this year’s Ira Sohn Conference when he compared Valeant Pharmaceuticals Intl Inc (NYSE:VRX) to a young version of Warren Buffett’s Berkshire Hathaway, calling both “platforms” for investments in other businesses.

Right or wrong, Ackman certainly is one to eat his own cooking. Ackman’s Pershing Square Capital Management initiated a massive position in Valeant in the first quarter. This pharma “platform” now makes up fully 26% of his long portfolio. He’s also enjoyed a fantastic profit in a very short period of time. He bought at an average price of $177 per share, and as of this writing shares traded hands at $227.

Is there any upside left?

Maybe. In Ackman’s Ira Sohn presentation, he suggested the company was worth $250 per share or more. While Ackman is a brilliant investor, I might wait for a pullback before following him into this trade.

Valeant failed last year in its attempt to buy Botox maker Allergan Inc (NYSE:AGN), which was, until this quarter, Ackman’s largest holding. Allergan was instead acquired by Actavis PLC (NYSE:ACT), which coincidentally is a new holding of Ackman’s. Pershing Square initiated a new position in Actavis last quarter, and the stock now makes up about 2.7% of the portfolio.

If there is a theme to Ackman’s investing this year, it is healthcare. More than 40% of his fund is currently dedicated to health and pharmaceutical stocks.

Source: Investor Place

The most 'interesting' investment in Bill Ackman's portfolio that 'no one's really noticed'

Source: Business Insider

https://finance.yahoo.com/news/most-int ... 12325.html

Ackman's Pershing Square Extends Losses to 19% as Valeant Dives

By Saijel Kishan

Source: Bloomberg

http://finance.yahoo.com/news/ackmans-p ... 52719.html

In hedge fund news: activist investor William Ackman's Pershing Square Holdings portfolio tumbled 18.6 percent so far this year, according to an investor with knowledge of the numbers.

Source: Reuters

Remember Bill Ackman's 40% Hedge Fund Gain in 2014? It's All Gone.

Source: Reuters

http://fortune.com/2016/02/25/bill-ackman-fund-gain/

Bill Ackman's Pershing Square upped its stake in Restaurant Brands (QSR), the holding company of fast-food brands Burger King and Tim Hortons.

The activist investor also increased holdings in Valeant (VRX), which has recently plummeted.

Source: Reuters